Rachel Tsunemoto Hislop

As a Principal at Two Bear Capital, Rachel focuses on the scientific due diligence behind investment decisions and is passionate about accelerating innovations in disease prevention, diagnostics, and drug discovery. As a former academic researcher and Medical Science Liaison in biotech, Rachel’s experiences in the therapeutic development process span from preclinical to post-approval. Rachel has a PhD in Neurosciences from UC San Diego and her graduate work led to a first author publication in Nature. After hours, Rachel enjoys spending time with her husband and lovable husky, working out at the gym, trying new restaurants, and learning Spanish.